Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)
Homoharringtonine (HHT) has been widely used in China to treat patients with acute and chronic myeloid leukemia for decades. Since response to HHT varies among patients, our study aimed to identify biomarkers that might influence the response to HHT using a panel of various human lymphoblastoid cel...
Main Authors: | Liewei eWang, Yin eTong, Nifang eNiu, Gregory eJenkins, Liang eLi, Krishna Rani Kalari |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-01-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fgene.2014.00465/full |
Similar Items
-
The Metabolic Signature of AML Cells Treated With Homoharringtonine
by: Yulong Zhang, et al.
Published: (2022-06-01) -
Anti-Leukemic Effects of Typhonium Flagelliforme on Human Lymphoblastoid Cells (CEMss) and Murine Leukemic (WEHI-3) Model
by: Syam Mohan, Murali Mohan
Published: (2010) -
Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds
by: Sol Marcos, et al.
Published: (2021-08-01) -
Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial
by: Hua Jin, et al.
Published: (2023-04-01) -
TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment
by: Shuai Guo, et al.
Published: (2021-10-01)